143 related articles for article (PubMed ID: 37596456)
1. Expression of endocan and vascular endothelial growth factor and their correlation with histopathological prognostic parameters in pheochromocytoma.
Kocabaş M; Can M; Karaköse M; Esen HH; Kulaksizoğlu M; Karakurt F
Endocrine; 2023 Dec; 82(3):638-645. PubMed ID: 37596456
[TBL] [Abstract][Full Text] [Related]
2. Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis.
Strong VE; Kennedy T; Al-Ahmadie H; Tang L; Coleman J; Fong Y; Brennan M; Ghossein RA
Surgery; 2008 Jun; 143(6):759-68. PubMed ID: 18549892
[TBL] [Abstract][Full Text] [Related]
3. Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer.
Chang Y; Niu W; Lian PL; Wang XQ; Meng ZX; Liu Y; Zhao R
World J Gastroenterol; 2016 Jun; 22(23):5422-9. PubMed ID: 27340359
[TBL] [Abstract][Full Text] [Related]
4. Pheochromocytoma in Dogs Undergoing Adrenalectomy.
Zini E; Nolli S; Ferri F; Massari F; Gerardi G; Nicoli S; Romanelli G; Montinaro V; Trez D; Cavicchioli L; Ferro S
Vet Pathol; 2019 May; 56(3):358-368. PubMed ID: 30595108
[TBL] [Abstract][Full Text] [Related]
5. [Expression of transforming growth factor alpha, tumor necrosis factor alpha, and vascular endothelial growth factor of human pheochromocytoma tissues].
Tong AL; Zeng ZP; Yang D; Li HZ; Li M; Chen S; Sun ML
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):426-31. PubMed ID: 15379270
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological correlation of endocan expression and survival in epithelial ovarian cancer.
El Behery MM; Seksaka MA; Ibrahiem MA; Saleh HS; El Alfy Y
Arch Gynecol Obstet; 2013 Dec; 288(6):1371-6. PubMed ID: 23708323
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases.
Thompson LD
Am J Surg Pathol; 2002 May; 26(5):551-66. PubMed ID: 11979086
[TBL] [Abstract][Full Text] [Related]
8. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
9. Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma: A Comparison of PASS and GAPP Scoring Systems.
Wachtel H; Hutchens T; Baraban E; Schwartz LE; Montone K; Baloch Z; LiVolsi V; Krumeich L; Fraker DL; Nathanson KL; Cohen DL; Fishbein L
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4661-70. PubMed ID: 32877928
[TBL] [Abstract][Full Text] [Related]
10. Expression of the angiogenesis markers endocan in Cushing's syndrome due to cortisol producing adenoma.
Can M; Kocabaş M; Karaköse M; Esen HH; Kulaksızoğlu M; Karakurt F
Endocrine; 2023 Mar; 79(3):554-558. PubMed ID: 36350461
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Significance of Measuring Vascular Endothelial Growth Factor for the Differentiation between Malignant and Tuberculous Pleural Effusion.
Kim HR; Kim BR; Park RK; Yoon KH; Jeong ET; Hwang KE
Tohoku J Exp Med; 2017 Jun; 242(2):137-142. PubMed ID: 28626164
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
13. Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): can they predict malignancy?
Agarwal A; Mehrotra PK; Jain M; Gupta SK; Mishra A; Chand G; Agarwal G; Verma AK; Mishra SK; Singh U
World J Surg; 2010 Dec; 34(12):3022-8. PubMed ID: 20703467
[TBL] [Abstract][Full Text] [Related]
14. Malignant pheochromocytoma: new malignancy criteria.
de Wailly P; Oragano L; Radé F; Beaulieu A; Arnault V; Levillain P; Kraimps JL
Langenbecks Arch Surg; 2012 Feb; 397(2):239-46. PubMed ID: 22069042
[TBL] [Abstract][Full Text] [Related]
15. VEGF in 105 pheochromocytomas: enhanced expression correlates with malignant outcome.
Salmenkivi K; Heikkilä P; Liu J; Haglund C; Arola J
APMIS; 2003 Apr; 111(4):458-64. PubMed ID: 12780519
[TBL] [Abstract][Full Text] [Related]
16. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis.
Roudnicky F; Poyet C; Wild P; Krampitz S; Negrini F; Huggenberger R; Rogler A; Stöhr R; Hartmann A; Provenzano M; Otto VI; Detmar M
Cancer Res; 2013 Feb; 73(3):1097-106. PubMed ID: 23243026
[TBL] [Abstract][Full Text] [Related]
17. VEGF-A/VEGF-B/VEGF-C expressions in non-hereditary, non-metastatic phaeochromocytoma.
Abe I; Islam F; Lo CY; Liew V; Pillai S; Lam AK
Histol Histopathol; 2021 Jun; 36(6):645-652. PubMed ID: 33734425
[TBL] [Abstract][Full Text] [Related]
18. Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma.
Ferreira CV; Siqueira DR; Romitti M; Ceolin L; Brasil BA; Meurer L; Capp C; Maia AL
Int J Mol Sci; 2014 Mar; 15(4):5323-36. PubMed ID: 24675699
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
[TBL] [Abstract][Full Text] [Related]
20. Endocan expression and relationship with survival in human non-small cell lung cancer.
Grigoriu BD; Depontieu F; Scherpereel A; Gourcerol D; Devos P; Ouatas T; Lafitte JJ; Copin MC; Tonnel AB; Lassalle P
Clin Cancer Res; 2006 Aug; 12(15):4575-82. PubMed ID: 16899604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
